Protocol digest of a phase III trial to evaluate the efficacy of preoperative chemotherapy with S-1 plus oxaliplatin followed by D2 gastrectomy with postoperative S-1 in locally advanced gastric cancer: Japan Clinical Oncology Group study JCOG1509 (NAGISA Trial)

被引：3

作者：

Mizusawa, Junki ^{[1
]}

Tokunaga, Masanori ^{[2
]}

Machida, Nozomu ^{[3
]}

Yabusaki, Hiroshi ^{[4
]}

Kawabata, Ryohei ^{[5
]}

Imamura, Hiroshi ^{[6
]}

Kinoshita, Takahiro ^{[7
]}

Nomura, Takashi ^{[8
]}

Nunobe, Souya ^{[9
]}

Tsuji, Kunihiro ^{[10
]}

Katayama, Hiroshi ^{[1
]}

Fukuda, Haruhiko ^{[1
]}

Boku, Narikazu ^{[11
]}

Yoshikawa, Takaki ^{[12
]}

Terashima, Masanori ^{[13
]}

机构：

[1] Natl Canc Ctr, Japan Clin Oncol Grp, Data Ctr, Operat Off, Tokyo, Japan

[2] Tokyo Med & Dent Univ, Dept Gastrointestinal Surg, Tokyo, Japan

[3] Kanagawa Canc Ctr, Dept Gastroenterol, Yokohama, Kanagawa, Japan

[4] Niigata Canc Ctr Hosp, Dept Gastroenterol Surg, Niigata, Japan

[5] Osaka Rosai Hosp, Dept Surg, Osaka, Japan

[6] Toyonaka City Hosp, Dept Surg, Osaka, Japan

[7] Natl Canc Ctr Hosp East, Dept Gastr Surg, Kashiwa, Chiba, Japan

[8] Yamagata Prefectural Cent Hosp, Dept Surg, Yamagata, Japan

[9] Canc Inst Hosp, Dept Gastr Surg, Tokyo, Japan

[10] Ishikawa Prefectural Cent Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan

[11] Univ Tokyo, IMSUT Hosp, Inst Med Sci, Dept Oncol & Gen Med, Tokyo, Japan

[12] Natl Canc Ctr, Dept Gastr Surg, Tokyo, Japan

[13] Shizuoka Canc Ctr, Dept Gastr Surg, Shizuoka, Japan

来源：

JAPANESE JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 53卷 / 02期

关键词：

gastric cancer; preoperative chemotherapy; LYMPH-NODE DISSECTION; NEOADJUVANT CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; CISPLATIN; SURGERY; SURVIVAL;

D O I：

10.1093/jjco/hyac154

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In Japan, postoperative chemotherapy is a standard care for stage II/III gastric cancer after curative resection with D2 lymph node dissection, and the clinical outcomes of patients with stage Ill gastric cancer are unsatisfactory. A combination of oral S-1 and oxaliplatin, that is the standard chemotherapy regimen for unresectable advanced/recurrent gastric cancer associated with a high response rate, was considered the most promising preoperative chemotherapy regimen. This randomized phase Ill trial was started in September 2016 to confirm the superiority of preoperative chemotherapy with S-1 plus oxaliplatin followed by D2 gastrectomy with postoperative chemotherapy compared with D2 gastrectomy with postoperative chemotherapy for patients with clinical T3-4N1-3 M0 locally advanced gastric cancer in terms of overall survival. A total of 470 patients will be enrolled from 63 hospitals in Japan for 8.5 years. This trial has been registered in the Japan Registry of Clinical Trials as jRCTs031180350 [https://jrct.niph.go.jp/latest-detail/jRCTs031180350].

引用

页码：168 / 173

页数：6

共 50 条

[41] S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial
Hironaka, Shuichi
Sugimoto, Naotoshi
Yamaguchi, Kensei
Moriwaki, Toshikazu
Komatsu, Yoshito
Nishina, Tomohiro
Tsuji, Akihito
Nakajima, Takako Eguchi
Gotoh, Masahiro
Machida, Nozomu
Bando, Hideaki
Esaki, Taito
Emi, Yasunori
Sekikawa, Takashi
Matsumoto, Shigemi
Takeuchi, Masahiro
Boku, Narikazu
Baba, Hideo
Hyodo, Ichinosuke
LANCET ONCOLOGY, 2016, 17 (01): : 99 - 108
[42] Phase III study comparing triplet chemotherapy with S-1 and cisplatin plus docetaxel versus doublet chemotherapy with S-1 and cisplatin for advanced gastric cancer (JCOG1013).
Yamada, Yasuhide
Boku, Narikazu
Mizusawa, Junki
Iwasa, Satoru
Kadowaki, Shigenori
Nakayama, Norisuke
Azuma, Mizutomo
Sakamoto, Takeshi
Shitara, Kohei
Okuno, Tatsuya
Chin, Keisho
Nozaki, Akira
Nakamura, Masaki
Hara, Hiroki
Katayama, Hiroshi
Fukuda, Haruhiko
Yoshikawa, Takaki
Sano, Takeshi
Sasako, Mitsuru
Terashima, Masanori
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[43] A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial
Park, S. H.
Lim, D. H.
Sohn, T. S.
Lee, J.
Zang, D. Y.
Kim, S. T.
Kang, J. H.
Oh, S. Y.
Hwang, I. G.
Ji, J. H.
Shin, D. B.
Yu, J., I
Kim, K-M
An, J. Y.
Choi, M. G.
Lee, J. H.
Kim, S.
Hong, J. Y.
Park, J. O.
Park, Y. S.
Lim, H. Y.
Bae, J. M.
Kang, W. K.
ANNALS OF ONCOLOGY, 2021, 32 (03) : 368 - 374
[44] Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway
He, Ming-ming
Zhang, Dong-sheng
Wang, Feng
Wang, Zi-xian
Yuan, Shu-qiang
Wang, Zhi-qiang
Luo, Hui-yan
Ren, Chao
Qiu, Miao-zhen
Jin, Ying
Wang, De-shen
Chen, Dong-liang
Zeng, Zhao-lei
Li, Yu-hong
He, Yang-yang
Hao, Yuan-tao
Guo, Pi
Wang, Feng-hua
Zeng, Yi-xin
Xu, Rui-hua
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (01) : 69 - 79
[45] Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway
Xu, R.
Zeng, Y.
He, M. -M.
Zhang, D.
Wang, F.
ANNALS OF ONCOLOGY, 2015, 26 : 61 - 61
[46] S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
Koizumi, Wasaburo
Narahara, Hiroyuki
Hara, Takuo
Takagane, Akinori
Akiya, Toshikazu
Takagi, Masakazu
Miyashita, Kosei
Nishizaki, Takashi
Kobayashi, Osamu
Takiyama, Wataru
Toh, Yasushi
Nagaie, Takashi
Takagi, Seiichi
Yamamura, Yoshitaka
Yanaoka, Kimihiko
Orita, Hiroyuki
Takeuchi, Masahiro
LANCET ONCOLOGY, 2008, 9 (03): : 215 - 221
[47] Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway
Ming-ming He
Dong-sheng Zhang
Feng Wang
Zi-xian Wang
Shu-qiang Yuan
Zhi-qiang Wang
Hui-yan Luo
Chao Ren
Miao-zhen Qiu
Ying Jin
De-shen Wang
Dong-liang Chen
Zhao-lei Zeng
Yu-hong Li
Yang-yang He
Yuan-tao Hao
Pi Guo
Feng-hua Wang
Yi-xin Zeng
Rui-hua Xu
Cancer Chemotherapy and Pharmacology, 2017, 79 : 69 - 79
[48] Phase II study of preoperative chemoradiation with S-1 plus oxaliplatin in patients with locally advanced rectal cancer
Lee, Eun Mi
Hong, Yong Sang
Kim, Kyu-pyo
Lee, Jae-Lyun
Kim, Sun Young
Park, Young Suk
Choi, Doo Ho
Kim, Jong Hoon
Lim, Seok-Byung
Yu, Chang Sik
Kim, Jin Cheon
Lee, Ju Hee
Kim, Ah Young
Kim, Tae Won
CANCER SCIENCE, 2013, 104 (01) : 111 - 115
[49] Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway
He, Ming-ming
Xu, Rui-hua
Zhang, Dong-sheng
Wang, Feng
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[50] Phase II trial of S-1 plus cisplatin for neoadjuvant treatment of locally advanced gastric cancer
Omura, K.
Yoshikawa, T.
Nashirnoto, A.
Ohta, K.
Kinoshita, K.
Murakarni, N.
Yarnaue, H.
Nakajima, T.
ANNALS OF ONCOLOGY, 2008, 19 : 40 - 40

← 1 2 3 4 5 →